A Bio‐Orthogonal Engineered Chitosan Platform for Enhanced Mesenchymal Stem Cells Delivery and Function in Peripheral Nerve Repair
Advanced Materials · 2026
DOI: 10.1002/adma.202523237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Xueying Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Co-innovation Center of Neuroregeneration, NMPA Key Laboratory For Research and E…. Hauptthemen laut MEDLINE: Chitosan, Mesenchymal Stem Cells, Nerve Regeneration, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chitosan‐based mesenchymal stem cell (MSC) therapy strategies present a promising approach for peripheral nerves repair following injury. However, the therapeutic efficacy of MSCs is significantly hindered by low cell viability and suboptimal retention at the implantation site. Herein, a bio‐orthogonal strategy that covalently integrates MSCs with chitosan for nerve regeneration is presented. In vitro analysis revealed covalent combination enhanced adhesion and survival of MSCs on chitosan scaffolds via phosphoinositide 3‐kinase (PI3K) and protein kinase B (Akt) signaling pathway. Quantitative proteomics confirmed that these MSCs enhance the secretion of key neurotrophic factors for neuroregeneration. In vivo investigations utilizing a nerve crush injury model demonstrated that bio‐orthogonal‐mediated MSC therapy markedly improves cell retention at the lesion site. Furthermore, this innovative strategy actively modulates the immune microenvironment, accelerates Wallerian degeneration, promotes angiogenesis, and remodels the extracellular matrix, thereby expediting repair processes following peripheral nerve injury. Specifically, further evaluation utilizing a 10 mm sciatic nerve transection model demonstrated that the bio‐orthogonal strategy significantly enhanced the therapeutic efficacy of MSCs. Collectively, the approach developed in this study provides a simple, efficient, and translatable strategy for augmenting MSC‐mediated peripheral nerve repair. This work lays a solid theoretical foundation for the future clinical application of chitosan‐MSC composite materials in neuroregenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Co-innovation Center of Neuroregeneration, NMPA Key Laboratory For Research and Evaluation of Tissue Engineering Technology Products, Key Laboratory of…
- The Third Clinical Medical College, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, P. R. China.
ORCID-Profile: Yumin Yang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, X., Jiang, X., Liang, B., Deng, H., Ma, Y., Liu, X., Zhang, L., & Yang, Y. (2026). A Bio‐Orthogonal Engineered Chitosan Platform for Enhanced Mesenchymal Stem Cells Delivery and Function in Peripheral Nerve Repair. Advanced Materials. https://doi.org/10.1002/adma.202523237
Vancouver
Zhao X, Jiang X, Liang B, Deng H, Ma Y, Liu X, et al. A Bio‐Orthogonal Engineered Chitosan Platform for Enhanced Mesenchymal Stem Cells Delivery and Function in Peripheral Nerve Repair. Advanced Materials. 2026. doi:10.1002/adma.202523237
BibTeX
@article{Zhao2026,
author = {Zhao, Xueying and Jiang, Xingyu and Liang, Bingjie and Deng, Hui and Ma, Yuyang and Liu, Xin and Zhang, Luzhong and Yang, Yumin},
title = {A Bio‐Orthogonal Engineered Chitosan Platform for Enhanced Mesenchymal Stem Cells Delivery and Function in Peripheral Nerve Repair},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202523237}
}
EUVIMED